Carboxyamidotriazole is primarily investigated for its potential therapeutic applications in the field of medicine. It has been studied as an anti-cancer agent due to its ability to inhibit calcium signaling pathways, which play a critical role in tumor growth and metastasis. By blocking these pathways, it may help reduce the proliferation of cancer cells and limit their spread. Additionally, it has shown promise in reducing angiogenesis, the process by which tumors develop new blood vessels to support their growth. Beyond oncology, carboxyamidotriazole has been explored for its anti-inflammatory properties, potentially offering benefits in treating conditions like rheumatoid arthritis or other inflammatory disorders. Its ability to modulate cellular processes also makes it a candidate for research in diseases involving abnormal cell signaling.